rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2007-11-6
|
pubmed:abstractText |
Lymphocyte transformation test (LTT) is a safety and reproducible test to assess activation of drug-specific T cells in vitro; however, there are several practical concerns such as the time of testing and the influence of treatment. Our aim was to define the right timing to perform LTT for determining the causative agent in various types of drug reactions.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0105-4538
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1439-44
|
pubmed:meshHeading |
pubmed-meshheading:17983378-Adolescent,
pubmed-meshheading:17983378-Adult,
pubmed-meshheading:17983378-Aged,
pubmed-meshheading:17983378-Aged, 80 and over,
pubmed-meshheading:17983378-Child,
pubmed-meshheading:17983378-Child, Preschool,
pubmed-meshheading:17983378-Drug Eruptions,
pubmed-meshheading:17983378-Drug Hypersensitivity,
pubmed-meshheading:17983378-Eosinophilia,
pubmed-meshheading:17983378-Epidermal Necrolysis, Toxic,
pubmed-meshheading:17983378-Female,
pubmed-meshheading:17983378-Humans,
pubmed-meshheading:17983378-Infant,
pubmed-meshheading:17983378-Lymphocyte Activation,
pubmed-meshheading:17983378-Male,
pubmed-meshheading:17983378-Middle Aged,
pubmed-meshheading:17983378-Stevens-Johnson Syndrome,
pubmed-meshheading:17983378-T-Lymphocytes,
pubmed-meshheading:17983378-Time Factors
|
pubmed:year |
2007
|
pubmed:articleTitle |
Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption.
|
pubmed:affiliation |
Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|